BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 15606467)

  • 1. Full-field ERG, multifocal ERG and multifocal VEP in patients with retinitis pigmentosa and residual central visual fields.
    Gränse L; Ponjavic V; Andréasson S
    Acta Ophthalmol Scand; 2004 Dec; 82(6):701-6. PubMed ID: 15606467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
    Nagy D; Schönfisch B; Zrenner E; Jägle H
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease course of patients with pericentral retinitis pigmentosa.
    Sandberg MA; Gaudio AR; Berson EL
    Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocal visual evoked potentials to cone specific stimuli in patients with retinitis pigmentosa.
    Holopigian K; Shuwairi SM; Greenstein VC; Winn BJ; Zhang X; Carr RE; Hood DC
    Vision Res; 2005 Nov; 45(25-26):3244-52. PubMed ID: 16023698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of regional retinal responses on cortical visually evoked responses: multifocal ERGs and VEPs in the retinitis pigmentosa model.
    Parisi V; Ziccardi L; Stifano G; Montrone L; Gallinaro G; Falsini B
    Clin Neurophysiol; 2010 Mar; 121(3):380-5. PubMed ID: 20071230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of central retinal function in patients with advanced retinitis pigmentosa.
    Gerth C; Wright T; Héon E; Westall CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1312-8. PubMed ID: 17325178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifocal ERG reveals several patterns of cone degeneration in retinitis pigmentosa with concentric narrowing of the visual field.
    Janáky M; Pálffy A; Deák A; Szilágyi M; Benedek G
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):383-9. PubMed ID: 17197558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of retinal abnormalities on the multifocal visual evoked potential.
    Chen JY; Hood DC; Odel JG; Behrens MM
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4378-85. PubMed ID: 17003429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural course of ocular function in pigmented paravenous retinochoroidal atrophy.
    Choi JY; Sandberg MA; Berson EL
    Am J Ophthalmol; 2006 Apr; 141(4):763-5. PubMed ID: 16564825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa.
    Sandberg MA; Weigel-DiFranco C; Rosner B; Berson EL
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1693-8. PubMed ID: 8675413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
    Birch DG; Anderson JL; Fish GE
    Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human neural retinal transplantation.
    Humayun MS; de Juan E; del Cerro M; Dagnelie G; Radner W; Sadda SR; del Cerro C
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3100-6. PubMed ID: 10967070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local cone and rod system function in patients with retinitis pigmentosa.
    Holopigian K; Seiple W; Greenstein VC; Hood DC; Carr RE
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):779-88. PubMed ID: 11222541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of visual field progression in patients with retinitis pigmentosa.
    Grover S; Fishman GA; Brown J
    Ophthalmology; 1998 Jun; 105(6):1069-75. PubMed ID: 9627658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of multifocal electroretinogram.
    Kondo M; Miyake Y; Horiguchi M; Suzuki S; Tanikawa A
    Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):2146-50. PubMed ID: 7657552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implicit time topography of multifocal electroretinograms.
    Seeliger MW; Kretschmann UH; Apfelstedt-Sylla E; Zrenner E
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):718-23. PubMed ID: 9538878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on anisometropic amblyopia by simultaneously recording multifocal VEP and multifocal ERG].
    Feng LX; Zhao KX
    Zhonghua Yan Ke Za Zhi; 2005 Jan; 41(1):41-6. PubMed ID: 15774113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing residual visual function in severe vision loss.
    Ayton LN; Apollo NV; Varsamidis M; Dimitrov PN; Guymer RH; Luu CD
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1332-8. PubMed ID: 24481260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
    Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
    Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.